FR347M - Nouvelle 1,3-dihydroxy-2-amino-nonadec-4-yne utilisable en thérapeutique. - Google Patents

Nouvelle 1,3-dihydroxy-2-amino-nonadec-4-yne utilisable en thérapeutique.

Info

Publication number
FR347M
FR347M FR836980A FR836980A FR347M FR 347 M FR347 M FR 347M FR 836980 A FR836980 A FR 836980A FR 836980 A FR836980 A FR 836980A FR 347 M FR347 M FR 347M
Authority
FR
France
Prior art keywords
nonadec
yne
dihydroxy
usable
therapy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR836980A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
BASF Schweiz AG
Original Assignee
Ciba Geigy AG
Ciba AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR802753A external-priority patent/FR1277964A/fr
Application filed by Ciba Geigy AG, Ciba AG filed Critical Ciba Geigy AG
Priority to FR836980A priority Critical patent/FR347M/fr
Application granted granted Critical
Publication of FR347M publication Critical patent/FR347M/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/13—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by hydroxy groups
    • C07C205/14—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by hydroxy groups having nitro groups and hydroxy groups bound to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/24—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR836980A 1958-08-15 1960-08-29 Nouvelle 1,3-dihydroxy-2-amino-nonadec-4-yne utilisable en thérapeutique. Expired FR347M (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR836980A FR347M (fr) 1958-08-15 1960-08-29 Nouvelle 1,3-dihydroxy-2-amino-nonadec-4-yne utilisable en thérapeutique.

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CH6294458A CH373032A (de) 1958-08-15 1958-08-15 Verfahren zur Herstellung neuer threo- oder erythro-1,3-Dihydroxy-2-amino-alkine-(4)
FR802753A FR1277964A (fr) 1958-08-15 1959-08-13 Nouveaux amino-diols aliphatiques non saturés et procédé pour leur préparation
FR836980A FR347M (fr) 1958-08-15 1960-08-29 Nouvelle 1,3-dihydroxy-2-amino-nonadec-4-yne utilisable en thérapeutique.

Publications (1)

Publication Number Publication Date
FR347M true FR347M (fr) 1961-03-27

Family

ID=4524641

Family Applications (2)

Application Number Title Priority Date Filing Date
FR836982A Expired FR349M (fr) 1958-08-15 1960-08-29 Nouvelle 1,3-dihydroxy-2-nitro-tricos-4-yne utilisable en thérapeutique.
FR836980A Expired FR347M (fr) 1958-08-15 1960-08-29 Nouvelle 1,3-dihydroxy-2-amino-nonadec-4-yne utilisable en thérapeutique.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FR836982A Expired FR349M (fr) 1958-08-15 1960-08-29 Nouvelle 1,3-dihydroxy-2-nitro-tricos-4-yne utilisable en thérapeutique.

Country Status (4)

Country Link
US (1) US3164636A (fr)
CH (1) CH373032A (fr)
FR (2) FR349M (fr)
GB (1) GB924876A (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3247054A (en) * 1964-03-02 1966-04-19 Commercial Solvents Corp Inhibiting the growth of algae in water with amino-substituted higher alkanol containing from about 8 to 18 carbon atoms

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2196554A (en) * 1937-04-16 1940-04-09 Melle Usines Sa Process for the manufacture of primary hydroxyalkylamines
US2163720A (en) * 1937-07-20 1939-06-27 Union Carbide & Carbon Res Lab Preparation of acetylenic alcohols
US2232867A (en) * 1937-08-27 1941-02-25 Gen Aniline & Film Corp Production of alkinols
US2194314A (en) * 1938-07-16 1940-03-19 Du Pont Preparation of n-substituted alkylol amines
US2375536A (en) * 1943-12-10 1945-05-08 Petrolite Corp Process for breaking petroleum emulsions

Also Published As

Publication number Publication date
US3164636A (en) 1965-01-05
FR349M (fr) 1961-03-27
CH373032A (de) 1963-11-15
GB924876A (en) 1963-05-01

Similar Documents

Publication Publication Date Title
BE577296A (fr) Ergomètre.
FR302M (fr) Nouvelle m-butoxy-phénoxy-éthylamine utilisable en thérapeutique.
FR308M (fr) Nouvelle pyridyl-éthyl-guanidine utilisable en thérapeutique.
FR349M (fr) Nouvelle 1,3-dihydroxy-2-nitro-tricos-4-yne utilisable en thérapeutique.
FR1898M (fr) Nouvelle substance utilisable en thérapeutique.
FR164M (fr) Nouvelle hydrazine utilisable en thérapeutique.
FR221M (fr) Nouvelle guanidine utilisable en thérapeutique.
FR222M (fr) Nouvelle 2,5-bis-éthylene-imino-3,6-bis-acylamino-p-benzoquinone utilisable en thérapeutique.
FR163M (fr) Nouvelle phénoxy-éthylamine utilisable en thérapeutique.
FR353M (fr) Nouvelle quinoléine utilisable en thérapeutique.
BE581628A (fr) Etireur-tordeur.
FR310M (fr) Nouvelle aza-hexylene-imino-éthyl-guanidine utilisable en thérapeutique.
FR303M (fr) Nouvelle guanidine utilisable en thérapeutique.
BE596272A (fr) Nouvelle substance utilisable en thérapeutique.
FR350M (fr) Nouvel antibiotique lankavamycine utilisable en thérapeutique.
FR348M (fr) Nouveau glucofuranoside 3,5,6-substitué utilisable en thérapeutique.
DK106453C (da) Endoradiosonde.
BE577202A (fr) 6 alpha-methyl-1,4-prégnadiènes.
BE583856A (fr) Agent opacifiant utilisable en readiologie.
FR1494M (fr) Nouvelle création en thérapeutique.
FR115M (fr) Nouveau sulfonamide utilisable en thérapeutique.
FI29893A (fi) Svällbara, syrafasta vattenglaskitt
FR176M (fr) Nouvelles carbamylazétidines.
FR3137M (fr) Nouvel δ<4>-7α, 17α-diméthyl-17β-hydroxy-oestrene utilisable en thérapie.
FR116M (fr) Nouveau dérivé sulfonamidique utilisable en thérapeutique.